Editorial: Novel methods to advance diagnostic and treatment value of medical imaging for cardiovascular disease

Zahra Keshavarz‐Motamed, Juan C. del Álamo, Danny Bluestein, Elazer R. Edelman, Jolanda J. WentzelFrontiers in Bioengineering and Biotechnology 2022 · DOI · OpenAlex

Cardiovascular disease (CVD) remains a leading cause of global mortality, characterized by significant inter-subject variability in both anatomy and pathophysiology. Traditional imaging modalities, such as standard CT or 2D ultrasound, have long provided essential static views of cardiac structures. However, these "snapshots" often fall short of providing the functional, patient-specific data required to predict individual responses to treatment or surgery.

This editorial, published in Frontiers in Bioengineering and Biotechnology, synthesizes a Research Topic of 21 articles that explore the transition of cardiovascular imaging from a purely diagnostic tool to a predictive, personalized powerhouse. By integrating multimodality imaging with advanced computational techniques, researchers are now able to quantify morphology, biology, and hemodynamics simultaneously.

The Shift Toward Personalized Management

The core challenge addressed in this collection is the "crossroads" of technological advancement. The goal is to move beyond single-modality diagnosis toward an integrated approach that enables personalized patient management. By creating "in silico" (computer-based) models, clinicians can simulate surgical outcomes and intervention strategies before a patient ever enters the operating room.

Cutting-Edge Methodologies

The featured research employs several sophisticated methodologies to enhance the diagnostic and treatment value of imaging:

  • Computational Fluid Dynamics (CFD): CFD is used to characterize coronary hemodynamics and validate animal models (such as swine) for human vascular disease translation.
  • 4D Flow MRI: This non-invasive technique quantifies complex blood flow patterns in the heart and brain, offering superior resolution and diagnostic value compared to traditional 2D methods.
  • Machine Learning (ML): ML frameworks are being applied to predict the outcomes of procedures like MitraClip interventions in near real-time and to analyze echocardiographic images for various cardiomyopathies.
  • Data Assimilation: By combining voxel-based flow data from imaging with physics-based CFD solvers, researchers can significantly improve the spatial and temporal resolution of cardiovascular flow features.
  • Biomechanical Modeling: Patient-specific "biventricular models" allow for the simulation of surgical impacts, such as band insertions in congenital heart defects like Tetralogy of Fallot.

Key Insights and Clinical Impact

The integration of these tools has led to several critical insights:

  • Predictive Intervention: Imaging is no longer just about visualization; it is about simulation. For instance, ML can leverage augmented 3D echo data to predict the success of mitral valve repairs.
  • Hemodynamics as a Biomarker: 4D flow MRI reveals that blood movement patterns can serve as sensitive biomarkers for subtle phenotypic differences in conditions like atrial fibrillation.
  • Beyond Simple Stenosis: New metrics, such as Pericoronary Adipose Tissue (PCAT) derived from spectral CT, are emerging as vital indicators of disease severity that go beyond simple vessel narrowing.

Results and Validation

The studies highlight significant successes in both accuracy and efficiency. Research confirmed the validity of using swine-specific computational models to study human atherosclerosis. Furthermore, integrating intravascular ultrasound (IVUS) parameters with lesion length was shown to improve the diagnosis of intermediate coronary stenosis. Prognostically, MRI-derived indices of ventricular function (strain) proved effective in predicting intermediate-term mortality for patients undergoing transcatheter aortic valve replacement (TAVR). Notably, ML-based methods are overcoming the high computational costs of traditional simulations, providing results in near real-time.

Future Directions and Limitations

Despite these advancements, hurdles remain for widespread clinical adoption. High-fidelity simulations, such as fluid-structure interactions, are often too computationally expensive for routine use, necessitating faster ML-based surrogates. The ultimate goal is a comprehensive cardiovascular model that integrates imaging, mechanics, genomics, and cellular behavior. Moving these sophisticated tools from the research lab into standard clinical practice will require further validation and the development of user-friendly interfaces for clinicians.

Summary updated

Abstract

The use of medical imaging has substantially increased over the past decade, thanks to the technological advancements evident from the dramatic improvement in the sensitivity and spatial resolution of imaging modalities. Cardiovascular imaging has been at a crossroads regarding technological advances, with a shift in focus from single-modality diagnosis to an integrated multimodality approach that can provide comprehensive assessments of morphology, pathophysiology, and disease biology to stratify the patient risk and guide therapies. The wide inter-subject variability in cardiovascular anatomy and pathophysiology urges the design of personalized patient management, which can highly benefit from clinical imaging technologies. The remarkable advances in medical imaging have sparked the development of new image processing algorithms and image-based simulation tools. In addition to providing comprehensive diagnostic information, some tools can even predict intervention outcomes, thereby enabling personalized intervention planning. This Research Topic, Novel Methods to Advance Diagnostic and Treatment Value of Medical Imaging for Cardiovascular Disease, focuses on tools that augment the power of medical imaging to provide detailed quantification of cardiovascular disease. Here, we present a Research Topic of 21 research articles that provide the
BibTeX
@inproceedings{keshavarzmotamed2022editorial,
  author = {Zahra Keshavarz‐Motamed and Juan C. del Álamo and Danny Bluestein and Elazer R. Edelman and Jolanda J. Wentzel},
  title = {{Editorial: Novel methods to advance diagnostic and treatment value of medical imaging for cardiovascular disease}},
  booktitle = {Frontiers in Bioengineering and Biotechnology},
  year = {2022},
  doi = {10.3389/fbioe.2022.987326},
}
Figure